2025 Year10 Month1 Day,Global Leading Enterprise in the Field of Gene SequencingIllumina(NASDAQ stock code:ILMN) Announces the Official Launch of a New Business –BioInsight。This initiative aims to meet the industry's urgent need for in-depth biological insights, which stems from the challenges faced by researchers and pharmaceutical companies in accessing and interpreting the growing volume of multi-omics data.

BioInsight AsIllumina New businesses under the company,Focused on developing data assets, software, and artificial intelligence solutions, dedicated to driving breakthroughs in the life sciences field.Through integrationIllumina Advantageous resources in sequencing, data analysis, software, and artificial intelligence,BioInsight Will provide customized solutions for customers and partners.These solutions will help customers identify drug targets, understand biological pathways, discover new disease mechanisms, and thereby build the next wave of impactful biological insights, driving innovation and development in science and healthcare while providing momentum for the company's long-term sustainable growth.

Core Event Validation

BioInsightFocus on four major directions:

Large-Scale Project Collaboration

BioInsight Will actively collaborate with major national initiatives and industry partners to advance large-scale genetic and biological data generation projects.These projects will integrate multi-party resources, utilize advanced technical means, and generate high-quality, large-scale multi-omics data, providing a solid foundation for subsequent research and analysis.

Software Solution Development

Multi-modal data for population scale,BioInsight Will be committed to developing professional software solutions.These software programs will have powerful data processing and analysis capabilities, able to extract valuable information from massive multi-omics data, helping researchers gain deeper insights into biological processes and disease mechanisms.

Data Platform Construction

To promote cooperation and exchange in the fields of research and pharmaceuticals,BioInsight A secure and private data platform will be provided.The platform will provide partners with convenient data access channels while ensuring data security and privacy, promoting data sharing and collaborative research, and accelerating the process of scientific discovery.

Construction of Artificial Intelligence Tool Ecosystem

By establishing close cooperative relationships with strategic partners,BioInsight Will jointly develop artificial intelligence tools to build an ecosystem for large-scale multimodal data analysis.These artificial intelligence tools will leverage advanced algorithms and models to deeply mine and analyze multi-omics data, providing more precise decision support for drug development, disease diagnosis, and treatment.

BioInsight ByRami Mehio Served as Senior Vice President and General Manager.Mehio With rich industry experience, once ledIllumina Global Software and Informatics Team for Four Years, During Which He Demonstrated Exceptional Leadership and Technical Insight. His Joining the Company's Executive Team Will BringBioInsight The development brings a professional technical perspective and strategic guidance.

Illumina Chief Executive OfficerJacob Thaysen ToBioInsight development with full confidence. He stated: "By closely collaborating with our customers, we will push the boundaries of sequencing and break down the barriers between omics data generation and transformative insights. InRami Under the outstanding leadership ofBioInsight Will further consolidateIllumina Leadership in the intersection of sequencing, software, and artificial intelligence will focus on supporting pharmaceutical companies in the discovery and development of drug targets, bringing more innovative achievements to the life sciences field.”

BioInsight AndIllumina Focus on scalable data andAI The growth of solutions, this strategic initiative will drive customers to acquire rich omics data insights more quickly and efficiently.By accelerating transformative research and discovery,BioInsight Is expected to bring new breakthroughs and development opportunities to the field of life sciences, further enhancingIllumina In a leading position in the global gene sequencing and life sciences fields.